title: 13-valent pneumococcal vaccine: 50 years of age and older.
abstract: In adults, the 13-valent pneumococcal conjugate vaccine seems to be more immunogenic than the 23-valent polysaccharide pneumococcal vaccine for most of the 12 shared serotypes. However, in mid-2012, routine vaccination of adults has no proven efficacy.
mesh_terms: D000367:Age Factors; D006801:Humans; D008875:Middle Aged; D018579:Patient Selection; D011008:Pneumococcal Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors; D014611:Vaccination
chemical_list: C538862:13-valent pneumococcal vaccine; D022242:Pneumococcal Vaccines